Search Results for "Genital Squamous Cell Carinoma"

01:36 EDT 25th September 2016 | BioPortfolio

Matching Channels

Squamous Cell Carcinoma

Squamous cell carcinoma (SCC) is a carcinomatous cancer occurring in many different organs, including the skin, lips, mouth, esophagus, urinary bladder, prostate, lungs, vagina, and cervix. It is a ...

Oral Squamous Cell Carcinoma

CIN and squamous cell carcinoma stage IA1

Squamous cell cancer of the anus and vulva


Matching News

VIDEO: Nicotinamide may reduce risk for basal, squamous cell carcinoma

NEW YORK — Martin A. Weinstock, MD, PhD, professor of dermatology and community health at Brown University, discussed effective chemoprevention methods for basal cell carcinoma and squamous cell car...

Squamous Dysplasia in the Esophagus Tied to Risk of Additional Lesions

Patients with early-stage esophageal squamous cell carcinomas (SCC) and areas of dysplastic squamous epithelium are at increased risk of developing multiple SCCs, according to Japanese researchers. ...

Frequent PD-L1 Expression in Penile Squamous Cell Carcinoma

Are checkpoint inhibitors a new option for penile squamous cell carcinoma? Annals of Oncology

Nivolumab cost-effectiveness improves by selecting non-squamous NSCLC PD-L1 patients

Nivolumab (NIV), a checkpoint inhibitor approved for all squamous and non-squamous non-small cell lung cancer (NSCLC) patients in 2015, is not cost-effective when compared to treatment with docetaxel ...

Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas

Matthew Meyerson, Ramaswamy Govindan and colleagues examine the exome sequences and copy number profiles of 660 lung adenocarcinoma and 484 lung squamous cell carcinoma tumors. They identify novel sig...

FDA approves Boehringer Ingelheim's Gilotrif for squamous cell lung cancer

The US Food and Drug Administration (FDA) has approved Boehringer Ingelheim's supplemental New Drug Application (sNDA) for Gilotrif (afatinib) as new oral treatment option for patients with squamous c...

CANbridge Signs Agreement with Boehringer Ingelheim to Manufacture Inhibitory Antibody, CAN-017, for Esophageal Squamous Cell Cancer

Thursday, August 11th 2016 at 12:07pm UTC SHANGHAI–(BUSINESS WIRE)– Boehringer Ingelheim and CANbridge Life Sciences announced that both parties have signed an agreement for the manufactur...

Genocea releases positive results for genital herpes treatment GEN-003

Genocea Biosciences, a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, has announced positive 12 month efficacy data from its phase II dose optimization trial evalua...

Matching PubMed Articles

Biomarkers p16, HPV, and p53 Predict Recurrence and Survival in Early Stage Squamous Cell Carcinoma of the Vulva.

Vulvar squamous cell carcinoma (VSCC) develops through 2 distinct molecular pathways, one involving high-risk human papillomavirus (HPV) infection and the other through early p53 suppressor gene mutat...

Laryngeal Squamous Cell Carcinomas are Commonly Associated With Differentiated Squamous Intraepithelial Neoplasia With or Without an Admixture With Usual Type of Squamous Intraepithelial Neoplasia: Clinical and Pathologic Significance.

Differentiated squamous intraepithelial neoplasia (dSIN) is a pathway in the development of invasive squamous cell carcinoma (SCC) distinct from the usual-type squamous intraepithelial neoplasia (uSIN...

Pancreatic Squamous Cell Carcinoma: A Population-Based Study of Epidemiology, Clinicopathologic Characteristics and Outcomes.

Squamous metaplasia is commonly detected in pancreatic parenchyma; however, primary pancreatic squamous cell carcinoma (SCC) is a rare malignancy with unknown incidence and unclear prognosis.

Papillary Squamous Cell Carcinoma of the Cheek.

Papillary squamous cell carcinoma (PSCC) is a rare variant of squamous cell carcinoma. The predominant occurrence sites are larynx, oropharynx, and nasopharynx. Only a few patients have been reported ...

Oral Non Squamous Cell Malignant Tumors in an Iranian Population: a 43 year Evaluation.

The prevalence of non-squamous cell malignant tumors of the oral cavity has not been evaluated in Iran extensively. The aim of this study was to evaluate epidemiological aspects of the oral malignanci...

Search Whole site using Google

Quick Search
Advertisement Advertisement